When you (or someone you care for) are facing obsessive‑compulsive disorder (OCD) or severe anxiety, picking the right pill can feel like a gamble. Anafranil is the brand name for clomipramine, a tricyclic antidepressant (TCA) that has been used for OCD since the 1970s. It works by blocking the re‑uptake of serotonin and norepinephrine, which lifts mood and reduces compulsive thoughts. Because it’s older and has a distinct side‑effect profile, many patients wonder whether newer drugs might be safer or more effective. This article walks through the key points you need to decide if clomipramine is right for you, and how it stacks up against the most common alternatives.
Clomipramine belongs to the tricyclic class, which predates the selective serotonin re‑uptake inhibitors (SSRIs). Its dual action on serotonin and norepinephrine gives it a stronger pull on the brain circuits that drive compulsions. Clinical trials from the 1990s onward consistently report response rates of 60‑70% in OCD patients, compared with 45‑55% for most SSRIs.
Key pharmacological attributes:
Because of its anticholinergic load, clomipramine can cause dizziness and orthostatic hypotension in people over 65. That’s the main reason many clinicians reserve it for patients who have not responded to first‑line SSRIs.
Below are the six most frequently prescribed alternatives. Each entry includes a short micro‑definition so search engines can recognise the entity.
Fluoxetine is a selective serotonin re‑uptake inhibitor (SSRI) approved for OCD, depression, and bulimia.
Sertraline is an SSRI commonly used as first‑line therapy for OCD and panic disorder.
Fluvoxamine is an SSRI with the strongest evidence for OCD among the SSRI class.
Escitalopram is an SSRI noted for its favorable side‑effect profile and high receptor selectivity.
Paroxetine is an SSRI that can cause more weight gain and sexual side effects than other SSRIs.
Duloxetine is a serotonin‑norepinephrine re‑uptake inhibitor (SNRI) used for depression and pain syndromes, occasionally off‑label for OCD.
Attribute | Anafranil (Clomipramine) | Fluoxetine | Sertraline | Fluvoxamine | Escitalopram | Paroxetine |
---|---|---|---|---|---|---|
Drug class | Tricyclic (TCA) | SSRI | SSRI | SSRI | SSRI | SSRI |
Primary mechanism | Serotonin+Norepinephrine re‑uptake inhibition | Serotonin re‑uptake inhibition | Serotonin re‑uptake inhibition | Serotonin re‑uptake inhibition | Serotonin re‑uptake inhibition | Serotonin re‑uptake inhibition |
Typical OCD dose (mg) | 100‑250 | 20‑80 | 50‑200 | 50‑300 | 10‑20 | 20‑60 |
Half‑life (hours) | ~30 | 2‑3 (active metabolite 4‑6) | 26 | 15‑20 | 27-32 | 21 |
Response rate in OCD trials | 60‑70% | 45‑55% | 45‑55% | 50‑60% | 45‑55% | 40‑50% |
Common side effects | Dry mouth, constipation, dizziness, weight gain | Nausea, insomnia, sexual dysfunction | Diarrhea, insomnia, sexual dysfunction | Nausea, insomnia, sexual dysfunction | Headache, nausea, mild sexual side effects | Weight gain, sexual dysfunction, drowsiness |
Serious risk | Cardiac conduction changes (QT prolongation) in high doses | Serotonin syndrome (rare) | Serotonin syndrome (rare) | Serotonin syndrome (rare) | Serotonin syndrome (rare) | Serotonin syndrome (rare) |
Cost on NHS (generic) | £0.10‑£0.15 per tablet | £0.12‑£0.18 per tablet | £0.13‑£0.20 per tablet | £0.14‑£0.22 per tablet | £0.15‑£0.23 per tablet | £0.13‑£0.19 per tablet |
If you have tried two different SSRIs at therapeutic doses for at least 12 weeks each and still see only marginal improvement, the evidence suggests clomipramine may push you into the responder zone. Its stronger norepinephrine effect also helps patients whose anxiety has a marked physical component (e.g., tremor, rapid heart rate).
Older adults with cardiac histories should avoid clomipramine unless the benefits clearly outweigh the risks. In such cases, an SSRI with a clean cardiac profile-like escitalopram-is generally safer.
Patients often report that the “sedating start” of clomipramine fades after the first month, making it a viable long‑term option when other drugs fail.
Combining a TCA with an SSRI dramatically raises the risk of serotonin syndrome, a potentially life‑threatening condition. Doctors only do this when the benefit is clear and the patient is closely monitored, usually with a very low SSRI dose and a gradual taper of clomipramine.
Most patients notice a reduction in compulsive thoughts after 4‑6 weeks at a therapeutic dose, but full response can take up to 12 weeks. Patience and steady titration are key.
Clomipramine is classified as Category B in the UK, meaning animal studies haven’t shown risk but human data are limited. Most clinicians prefer an SSRI like fluoxetine if a patient becomes pregnant while on treatment.
Clomipramine often causes dry mouth, constipation, and occasional dizziness due to its anticholinergic action. Sertraline’s most common complaints are gastrointestinal-nausea and diarrhea-plus occasional insomnia. Sexual dysfunction can occur with both, but it’s typically milder with sertraline.
Routine blood work isn’t required for most patients, but a baseline liver function test and ECG are advised, especially for doses above 200mg or in patients with cardiac history.
1. Schedule an appointment with your GP or psychiatrist and bring a list of all current meds.
2. Discuss whether you’ve completed an adequate trial of at least two SSRIs (12 weeks each, at max dose).
3. If the answer is yes, ask about a clomipramine trial, emphasizing the need for ECG monitoring if you’re over 60.
4. Ask for a clear taper plan if you need to stop an existing SSRI.
5. Keep a symptom diary for the first 8 weeks; note any side effects, sleep changes, or new anxiety patterns.
Switching meds can feel daunting, but with a step‑by‑step plan you’ll know exactly what to expect and when to call your prescriber.
Choosing the right OCD medication isn’t a one‑size‑fits‑all decision. By weighing efficacy, safety, cost, and personal health factors, you can land on the option that gives you the most relief with the fewest unwanted effects.
Comments (1)
Brad Tollefson October 14 2025
Clomipramine works, but the dry mouth can be a real pain.